Evidence map›Paper›PMID 3387443›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1988

Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy.

B Cederholm, J Wieslander, P Bygren, D Heinegård

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1988. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Autoimmunity in IgA nephropathy.Frontiers in immunology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nephrology, dialysis and transplantation.Postgraduate medical journal · 1993
    Review
  13. Pathogenesis of idiopathic IgA nephropathy.Pediatric nephrology (Berlin, Germany) · 1993
    Review
  14. Autoimmunity and glomerulonephritis.Postgraduate medical journal · 1992
    Review
  15. Article
  16. Article
  17. Article
  18. The structure and function of human IgA.The Biochemical journal · 1990
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

B CederholmDepartment of Nephrology, University Hospital, Lund, Sweden.
J Wieslander
P Bygren
D Heinegård

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgA antibodies from patients with primary IgA nephropathy bind to collagens I, II, and IV. Here we show that this binding is mediated by the collagen-binding site of fibronectin, which occurs in the circulation in complex with IgA. No antibodies binding directly to collagen were identified. The complexes were isolated by affinity chromatography on gelatin-Sepharose and heparin-Sepharose, both with affinity for fibronectin, followed by adsorption to anti-human IgA immobilized on agarose gel. The presence of fibronectin and IgA antibodies in the isolated complexes is shown by enzyme-linked immunosorbent assay, gel electrophoresis, and electrophoretic transfer followed by immunostaining. The presence of an IgA-fibronectin complex in serum and the binding of this complex to collagen demonstrate the necessity of removing fibronectin from serum prior to identifying anti-collagen antibodies.

Indexed as

AdsorptionAntibody SpecificityAntigen-Antibody ComplexAutoantibodiesBinding SitesChromatography, AffinityCollagenFibronectinsGelatinGlomerulonephritis, IGAHeparinHumansImmunoglobulin ASepharoseAntigen-Antibody ComplexAutoantibodiesCollagenFibronectinsGelatinHeparinImmunoglobulin ASepharose

Identifiers

PMID3387443
PMCPMC280537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.